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The fate of breast cancer patients after local curative resection
depends on the capacity of the primary tumour cells to disseminate
to distant organs in an early stage of cancer. The identification
of tumour cell dissemination on a single-cell level, termed
micrometastases, has been considered a direct approach to
defining the disseminative potential of a tumour and a practical
tool to identify patients at high risk for tumour recurrence (Cote
et al, 1991; O’Sullivan et al, 1997).
Bone marrow represents an optimal destination site for
micrometastatic breast cancer cells, however, it is not clear
whether their presence in the marrow represents true residual
disease, cell shedding from the primary tumour and/or metastatic
potential of the primary tumour (Diel et al, 1992; Ross et al, 1993;
Martin et al, 1998). Thus, the bone marrow microenvironment in
addition to its role in self-renewal, commitment and maturation of
the haemopoietic stem cell (Klein, 1995), seems also to be an
appropriate ‘niche’ for homing, attachment, dormancy, modula-
tion of growth and development of disseminated micrometastatic
cells. This distinctive property of the marrow microenvironment is
probably related to the competence of stromal cells to produce a
combination of cytokines, extracellular matrix molecules and by
their ability to establish heterotypic cell–cell contacts (Tavassoli
and Minguell, 1991; Chichester et al, 1993; Klein, 1995).
While several cellular and molecular aspects of the interaction
between breast epithelial cells with its surrounding mammary
stroma has been well established (Sawhney et al, 1992; Hazan
et al, 1997), their interaction with elements of the marrow stroma
is poorly understood. Among the cellular complexity of marrow
stroma exists a subset of non-haematopoietic cells referred as
mesenchymal stem cells (MSC), which display a potential for self-
renewal, proliferation and differentiation (Prockop, 1997; Conget
and Minguell, 1999). These properties confer to the multipotential
MSC the capability to serve as long-lasting precursors for bone,
cartilage, connective and muscular tissue (Pereira et al, 1995;
Ferrari et al, 1998). Together, MSC produce a vast array of
cytokines and extracellular matrix molecules (Haynesworth et al,
1996; Prockop, 1997) and express receptors and/or counter-
receptors both for cell–cell and cell–matrix interactions (Prockop,
1997; Conget and Minguell, 1999).
All these attributes make the MSC an interesting cell phenotype
to investigate their potential to interact with tumour epithelial
cells. The above mentioned interest is further strengthened by the
observation that long-term marrow stromal cells provide an advan-
tageous environment for the adhesion but not for the growth of
mammary epithelial cells (Brooks et al, 1997). Since long-term
marrow stromal cells differ from MSC in immunophenotype and
multipotential capabilities (Prockop, 1997; Majumdar et al, 1998),
we have initiated studies to investigate the growth pattern,
morphogenetic organization and expression of cell–cell adhesion
molecules in an epithelial breast cancer cell, after interacting in a
co-culture system with marrow-derived mesenchymal stem cells.
MATERIALS AND METHODS
Cell sources
Bone marrow MSC were prepared from leftover material obtained
from heparinized bone marrow samples from normal individuals
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undergoing marrow harvests for allogeneic transplantation
(Satomura et al, 1998; Conget and Minguell, 1999). Briefly,
marrow mononuclear cells were suspended in a-MEM (modified
essential medium) containing 20% fetal calf serum (FCS; Gibco-
BRL, NY, USA), seeded in T-25 flasks (1 ´ 106 cells cm–2) and
cultured (37°C, 5% carbon dioxide (CO2)). One week later, the
evolving adherent cell layer was trypsinized (0.25% trypsin,
Sigma, St Louis, MO, USA), resuspended and subcultured.
Adherent cells after the third subculture, here referred to as MSC,
were used for the experiments described.
The 3T3 fibroblastic cell line (ATCC, CCL 92), a competent
feeder layer for studies of mesenchymal and epithelial interactions
(Watt, 1994), was used as a control for co-culture studies. Cells
were seeded at 5 ´ 103 cells cm–2 in culture medium and incubated
at 37°C in an atmosphere of 5% CO2. After 1 week, the confluent
monolayer was trypsinized and cells were maintained by weekly
passages at 1:5 to 1:10 dilution.
MCF-7, an established human metastatic breast cancer cell line
widely utilized as a test cell for studies of mammary epithelial
cells and their interaction with the surrounding stroma (Ryan et al,
1993; Dong-Le Bourhis et al, 1997), was used in these studies.
Cells (ATCC, HTB 22) were seeded at 10 ´ 103 cells cm–2 in
culture medium and incubated at 37°C in an atmosphere of 5%
CO2. After 1 week, adherent cells were trypsinized and weekly
passaged at 1:10 to 1:20 dilution.
Co-culture of MCF-7 cells with monolayers of MSC or
3T3 cells
Co-cultures were established by plating MCF-7 cells (20–30 ´ 103
in 5 ml of culture medium) in T-25 flasks containing a confluent
monolayer of MSC or 3T3 cells. At these conditions, the number
of MCF-7 cells relative to total cell number in the co-cultures was
4–6%. After a 4-h incubation period, non-adherent or loosely
adherent cells were eliminated by three washings with phosphate-
buffered saline (PBS) containing 2% FCS. Culture medium was
readded and co-cultures were incubated at 37°C for various time
periods, with a change of medium every 48 h. At the completion of
each incubation period, the adherent layers (of at least three T-25
flasks) were detached either by exposure to a trypsine (0.25%
in 0.2 mM EDTA) or a EDTA (1 mM EDTA in PBS) solution.
Detached cells in PBS–2% BSA (bovine serum albumin) and
brought to a single-cell suspension by pipetting, were used for cell
count (haemocytometer) and viability determination (trypan blue)
and to measure the number of immunoreactive MCF-7 cells by
flow cytometry.
Table 1 Expression of E-cadherine and ESA on MCF-7 cells
Co-culture of MCF-7 with: E-cad ESA
(relative expression*)
3T3 1.00 1.00
MSC 0.42 0.36
Co-cultures of MCF-7 with 3T3 or MSC cells (day 4) were analysed for
E-cadherine (E-cad) and ESA expression, as indicated under Materials and
Methods. *For each condition, the mean fluorescence intensity of each
antigen was measured and relative values calculated with respect to MFI for
E-cad and ESA expression in co-cultures with 3T3, which were set to 1. Data
shown are representative of two experiments in duplicate, with s.d. values
always less than 10%.
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Figure 1 Representative growth curves for MCF-7, MSC and 3T3 cells. At each culture time, the total number of 3T3 (s s), MSC (l l) and MCF-7 (n n) cells was
counted (haemocytometer chamber) and expressed as fold increase over the respective starting cell number, which was set to 1. For each cell line, at the
indicated day of culture (arrow), cell cycle status was assessed by DNA content analysis. Inset shows the percentage of cells at each phase of the cell cycle
(dash = G1/G0, open = S, close = G2/M)1292 H Hombauer and JJ Minguell
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Antibody staining
To detect the intracellular antigen, cytokeratin peptide 18
(CK18), cells were permeabilized (70% ethanol, 10 min, 4°C), and
incubated (30 min at 4°C) with fluorescein isothiocyanate (FITC)-
conjugated anti-cytokeratin peptide 18 (CK18) monoclonal anti-
body (Sigma). As isotype control, FITC-conjugated mouse IgG1
antibody (Becton Dickinson, San José, CA, USA) was used. To
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Figure 2 Expression of antigens CK18 and ESA in MCF-7, 3T3 and MSC cells. Relative number of cells is presented versus fluorescence intensity. The
fluorescence profile (log scale) of unstained cells (dotted line) is compared with the same cell suspension after labelling with the indicated antibody (solid line).
These data are representative of four experimentsEpithelial and mesenchymal cells interaction 1293
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detect the surface-associated epithelial-specific antigen (ESA),
cells were incubated with anti-human ESA monoclonal antibody
(Sigma), followed by incubation with FITC-conjugated antimouse
IgG (wm) antibody (Sigma). For CK18 and ESA studies, the
concentration of the primary antibody for the cell number used
was previously established by titration. For E-cadherin (E-Cad)
staining, cells were labelled with an anti-rat uvomorulin (L-CAM)
monoclonal antibody (Sigma) and further incubated with a FITC-
conjugated anti-rat IgG antibody (Sigma). Flow cytometric
analysis was performed using a FACScan flow cytometer
(Beckton Dickinson), using the CELLQUEST software. Usually,
10 000 events were obtained for analysis, although for co-culture
analysis, 40 000 events were obtained. For comparative purposes,
the mean fluorescence intensity (MFI) of each antigen is expressed
as the ratio of MFI for first antibody/MFI for control antibody.
Cell cycle analysis
For these studies, cells were permeabilized, labelled with 10 mg
ml–1 propidium iodine (Pl; Sigma), and treated with 0.1 mg ml–1
RNAase (Sigma). DNA content was analysed in a FACScan flow
cytometer, using the ModFIT software. Usually, 10 000 events
were obtained for analysis.
Microscopic evaluation of MCF-7 cells in co-culture
The organization status of MCF-7 cells in co-culture was evalu-
ated either by phase-contrast or by epifluorescence microscopy
after labelling with anti-CK18, anti-ESA or anti-E-Cad antibodies,
as indicated above. As seen under light or epifluorescence
microscopy, a cluster was defined as consisting of more than six
immunoreactive cells, in direct cell–cell contact without any inter-
cellular space.
RESULTS
Growth and cell cycle status of MCF, MSC and 3T3 cells
To define proper conditions for the co-culture experiments, each
cell type was set in culture and assessed for growth and cell cycle
status (Figure 1). While 3T3 and MSC cells grow and attained a
typical confluence growth-arrested phase (at around day 7), MCF-
7 cells reach a rapid semi-confluence condition (day 5), beyond
which proliferation still occurs, but at a lower rate. The above was
further documented by DNA content analysis, which show that by
day 7 of culture more than 90% of MSC and 3T3 cells were in the
G0/G1 phase of the cell cycle (Figure 1, inset). For MCF-7 (day
5), the fraction of cells at G0/G1 was 60%, being the rest of cells
at S or G2/M.
Detection of immunoreactive MCF-7 cells by flow
cytometry
To validate a method to distinguish and enumerate immunoreac-
tive MCF-7 cells, particularly for the co-culture experiments, titra-
tion studies were performed to establish a proper concentration of
antibody (anti-CK18 or anti-ESA) that assures a high fluorescence
signal for MCF-7 and a low or meaningless signal for MSC and
3T3 cells. As seen in Figure 2, at the antibody concentration
selected (1/400 and 1/800 dilution for CK18 and ESA respec-
tively), MCF-7 cells express both antigens with high fluorescence
intensities (MFI ³ 40), whereas the expression of both antigens in
MSC and 3T3 cells was negligible (MFI ≤ 2). To further validate
the immunofluorescence method to enumerate MCF-7 cells, MSC
or 3T3 cells were mixed at different proportions (2–15%) with
MCF-7. After labelling with anti-CK18 antibody and enumeration
of immunoreactive cells by flow cytometry, the average recovery
of MCF-7 cells was 97 ± 6% (n = 7).
Proliferation of MCF-7 cells in co-culture with
monolayers of MSC or 3T3 cells
Co-cultures were established by seeding MCF-7 cells (see
Figure 1, arrow) on top of monolayers of 3T3 or MSC cells (see
Figure 1, arrows). Results in Figure 3 show the time-dependent
accumulation of immunoreactive (CK18+) MCF-7 cells on each
monolayer. It can be seen that the growth of MCF-7, after 5 days in
co-culture, is not significantly different beween both monolayers.
Similar results were obtained when MCF-7 cells in the co-culture
were labelled with anti-ESA antibody to track their proliferation
(data not shown). Longer co-culture periods (> 6 days) were not
analysed, due to detachment of the MSC or 3T3 monolayer from
the culture vessels.
Aggregation status of MCF-7 cells in co-culture with
MSC or 3T3 cells
To investigate the morphological features of MCF-7 cells in co-
culture, cells were observed in situ under phase-contrast or by
epifluorescence microscopy after labelling with anti-CK18, anti-
ESA or anti-E-Cad antibodies. As visualized under phase-contrast
microscopy, MCF-7 cells either in clusters or as single cells appear
to be attached to all over the fibroblastoid-like cells forming
the 3T3 and MSC monolayers respectively (Figure 4, A, B). In
co-culture with 3T3 cells, immunoreactive MCF-7 cells were
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Figure 3 Proliferation of MCF-7 cells in co-culture with monolayers of 3T3
and MSC cells. MCF-7 cells were seeded on a confluent monolayer of MSC
(l l) or 3T3 (s s) cells. At the indicated culture time, cells were stained for
CK18 and immunoreactive cells were enumerated by flow cytometry. The
number of CK18+ cells in the co-culture was calculated and expressed as
fold increase over the respective number of seeded MCF-7 cells, which was
set to 1. Each data point represents the mean ± s.e.m. of at least three
experiments1294 H Hombauer and JJ Minguell
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D
Figure 4 Photomicrographs showing clustered or single MCF-7 cells in co-culture with 3T3 and MSC cells. Photomicrographs were taken on
co-cultures (4 days) of MCF-7 cells with 3T3 (left) or MSC (right) cells. Panels A and B show unstained cells, as visualized under phase-contrast microscopy.
Arrows indicate clustered (ç) or single (®) cells. Other panels show immunoreactive MCF-7 cells after staining with antibodies against: CK18 (C and D), ESA
(E and F) and E-Cadherin (G and H). Notice that for co-cultures with MSC and after labelling with anti-E-Cad (H), since the fluorescence signal is weak, the film
was over-exposed to get the microphotograph. Scale bars: 70 mm (A, B); 35 mm (C, D, E, F); 14 mm (G, H)visualized as growing in clusters of > 6 round cells in direct
cell–cell contact and without any visible intercellular space
(Figure 4, C, E and G). Small clusters (2–5 cells) and few single
immunoreactive cells were only seen at the initial stages of the co-
culture. Conversely, in co-culture with MSC, immunoreactive
MCF-7 cells have lost their aggregation status and are visualized
as single cells, even after prolonged periods of co-culture (Figure
4, D, F and H).
Expression of intercellular adhesion molecules in
MCF-7 cells in co-culture
The expression of E-cadherine and ESA on MCF-7 cells in co-
culture was assessed to investigate whether changes in the expres-
sion of the adhesion molecules, may explain why MCF-7 grow in
cluster on 3T3 but disperse on MSC. As shown in Table 1, the rela-
tive expression of both intercellular adhesion molecules was 60%
lower in MCF-7 cells in co-cultures with MSC than with 3T3 cells.
DISCUSSION
The degree to which micrometastases within the bone marrow of
patients with breast cancer represents true residual disease, cell
shedding and/or metastatic potential is unclear (Funke et al, 1996;
O’Sullivan et al, 1997). In addition, the correlation between the
presence of epithelial tumour cells in mesenchymal cell samples
(blood or bone marrow), with prognosis or other clinical and
pathological features, has also been controversial. While some
authors have reported that finding one tumour cell among 106 bone
marrow cells is an independent prognostic factor for a higher inci-
dence of recurrent metastatic disease (Cote et al, 1991; Martin et
al, 1998), others have found no such correlation (Singletary et al,
1991; Molino et al, 1997). Whether the discrepancy reflects diver-
sity in patient disease status, selection of methodological proce-
dures to detect and enumerate cancer cells or in the origin of
cancer cells in the marrow (micrometastases vs trapped circulating
tumour cells) is a matter not yet established. However, an addi-
tional interpretation may be found in the notion that the outcome
of the micrometastatic cell depends on the nature and status of the
interacting stromal counterpart (Adam et al, 1994; Hazan et al,
1997).
In this vein, we have investigated whether marrow
mesenchymal cells provide the tumour cell with an advantageous
environment for adhesion, proliferation and morphogenetic
organization. MSC, based on their self-renewal, proliferative and
differentiation potential (Prockop, 1997; Conget and Minguell,
1999), appear as a suitable cell-target for epithelial tumour cells.
With the model system here used, we found that after interacting
with MSC, the breast cancer cell line MCF-7 displayed the
following features:
1. MCF-7 cells once attached to the monolayer of MSC, start to
proliferate at a rate that permits an eightfold increase in cell
number in about 5 days. However, proliferation of MCF-7 on
MSC was not better than on a feeder layer of 3T3 cells. These
data concur with previous findings showing that regardless the
tissue source, stromal cells stimulated the growth of MCF-7
(van Roozendaal et al, 1992) or breast cancer-derived epithelial
cells (Brooks et al, 1997).
2. The microscopic evaluation of MCF-7 cells in co-culture with
MSC, revealed that more than 80% of MCF-7 were present as
single cells lying close together without any evidence of direct
cell–cell contacts. This lack of organization contrasts with the
aggregation status exhibited by MCF-7 cells in co-culture with
3T3 or cultured on an inert plastic surface (not shown). Under
these conditions, MCF-7 cells grow in well organized clusters
exhibiting cell–cell contacts and few intercellular spaces. Our
results are different to those reported by Brooks et al (1997),
who showed that primary cultures of epithelial cells once
attached to a monolayer of long-term marrow stroma, prolifer-
ates and give rise to clusters (colonies) of epithelial cells.
Despite that MSC and long-term marrow stromal cells are both
considered as ‘stromal cells’, the evolving phenotypes, the
differentiation potential and secretion products (cytokines and
matrix molecules), are quite different (Chichester et al, 1993;
Prockop, 1997; Majumdar et al, 1998; Conget and Minguell,
1999). On the other hand, our results related to the transition of
clustered to single MCF-7 cells, resemble the appearance of
micrometastatic cells in the marrow of breast cancer patients.
Thus, it has been reported that when the load of immunoreac-
tive cancer (CK18+) cells is low, single cells are detectable in
the marrow, whereas as their numbers increase, cell clusters
predominate (Funke et al, 1996; Müller et al, 1996).
3. The expression of two main epithelial intercellular adhesion
molecules, E-cad and ESA, seems to be down-regulated in
MCF-7 cells in co-culture with MSC, as compared to 3T3. We
speculate that the extent of E-cad and ESA down-regulation is
sufficient to avoid homotypic cell adhesion; hence single and
not clustered MCF-7 cells develop on MSC. Our observation
of single breast cancer epithelial cells with low expression of
E-cad is not without precedent. In micrometastatic cells
derived from breast cancer patients, such cells are present
(Funke et al, 1996) and are probably derived from a primary
tumour with an elevated invasive potential (Takeichi, 1991;
Funke et al, 1996).
Taken together, the results here reported indicate that the inter-
action of MCF-7 cells with human bone marrow mesenchymal
stem cells, confers the tumour cell distinctive features that may
define their outcome in the marrow. The co-culture system used
here will allow further investigations towards a better under-
standing of the cellular and molecular events occurring at the inter-
face of epithelial–mesenchymal interactions. In addition it should
permit us to evaluate the significance and prognostic impact of the
shift of micrometastatic cells from a cluster-aggregated to a single-
cell status (Funke et al, 1996; Muller et al, 1996, Frixen et al,
1998).
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